Advertisement
Journal Home
Search for

Volume 154, Issue 1, Pages 17-19 (January 2009)


View previous. 22 of 64 View next.

Mid-Pregnancy Cotinine and Risks of Orofacial Clefts and Neural Tube Defects

Gary M. Shaw, DrPHaCorresponding Author Informationemail address, Suzan L. Carmichael, PhDa, Stein Emil Vollset, DrPHb, Wei Yang, MDa, Richard H. Finnell, PhDc, Henk Blom, PhDd, Øivind Midttun, PhDe, Per M. Ueland, MDef

Received 21 April 2008; received in revised form 30 June 2008; accepted 5 August 2008. published online 06 November 2008.

Refers to article:
Looking Ahead to a Tobacco-Free Generation , 06 November 2008
Cynthia F. Bearer, Matthew A. Stefanak
The Journal of Pediatrics
January 2009 (Vol. 154, Issue 1, Pages 4-5)
Full Text | Full-Text PDF (70 KB)
Maternal Smoking during Pregnancy and Newborn Neurobehavior: Effects at 10 to 27 Days , 06 November 2008
Laura R. Stroud, Rachel L. Paster, George D. Papandonatos, Raymond Niaura, Amy L. Salisbury, Cynthia Battle, Linda L. Lagasse, Barry Lester
The Journal of Pediatrics
January 2009 (Vol. 154, Issue 1, Pages 10-16)
Abstract | Full Text | Full-Text PDF (128 KB)
Objective

Past studies of cigarette smoking as a contributor to orofacial clefts and neural tube defects (NTDs) used self-reports of smoke exposures. We have correlated measurements of cotinine (a nicotine metabolite) in mid-pregnancy sera with clefts and NTDs.

Study design

From a repository of >180 000 mid-pregnancy serum specimens collected in California from 2003 to 2005 and linked to delivery outcome information, we identified 89 orofacial cleft-associated pregnancies, 80 NTD-affected pregnancies, and randomly selected 409 pregnancy specimens that corresponded to infants without malformations as control subjects. Cotinine was measured by liquid chromatography-mass spectrometry. No smoke exposure was defined as cotinine values <2 ng/mL, and any exposure was defined as ≥2 ng/mL.

Results

We observed odds ratios of 2.1 (95% CI, 1.0-4.4) for clefts and 0.4 (95% CI, 0.1-1.7) for NTDs associated with exposure. After adjusting for race/ethnicity, age, and serum folate levels, odds ratios were 2.4 (95% CI, 1.1-5.3) and 0.6 (95% CI, 0.1-2.5). We explored 2 cotinine levels, 2 to 10 ng/mL and >10 ng/mL for clefts (data were too sparse for NTDs). Odds ratios for these levels were 3.3 (95% CI, 0.9-11.9) and 1.7 (95% CI, 0.7-4.2), respectively.

Conclusion

Smoking exposures, as measured with cotinine levels during mid-pregnancy, were associated with increased risks of clefts and possibly reduced risks of NTDs.

a March of Dimes California Research Division, Children's Hospital Oakland Research Institute, Oakland, CA

b Medical Birth Registry of Norway, Norwegian Institute of Public Health, Bergen, Norway

c Institute of Biosciences and Technology, The Texas A&M University System Health Science Center, Houston, TX

d Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands

e Bevital A/S, Armanuer Hansens Hus, Bergen, Norway

f Section for Pharmacology, Institute of Medicine, University of Bergen and Haukeland University Hospital, Armauer Hansens Huz, Bergen, Norway

Corresponding Author InformationReprint requests: Dr Gary Shaw, March of Dimes California Research Division, Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr Way, Oakland, CA 94609

 Supported by funds from the Centers for Disease Control and Prevention, Center of Excellence Award U50/CCU913241 and by NIH/NINDS R01 NS050249. The authors declare no potential conflicts of interest.

PII: S0022-3476(08)00680-X

doi:10.1016/j.jpeds.2008.08.006


View previous. 22 of 64 View next.

Advertisement